Globus Medical (GMED) Slips on Acquisition and Robotics Segment Challenges

1 week ago 3

Attiya Zainib

Thu, March 5, 2026 astatine 9:32 AM CST 3 min read

Invesco Ltd‘s “Small Cap Value Fund” released its Q4 2025 capitalist letter. A transcript of the missive tin beryllium downloaded here. The Invesco Small Cap Value Fund reported beardown results for Q4 2025, outperforming its Russell 2000 Value Index benchmark arsenic Class A shares delivered a quarterly instrumentality of 6.79%, compared to the benchmark’s 3.26%, with banal enactment successful the Information Technology assemblage contributing astir 2.90% to comparative show portion wellness attraction and financials detracted. For the afloat year, the money generated a 17.64% instrumentality versus 12.59% for the Russell 2000 Value Index. Management maintained greater vulnerability to economically delicate stocks and emphasized that small-cap worth equities stay attractively priced, noting that the Russell 2000 Value Index continues to commercialized astatine a humanities P/E discount comparative to the S&P 500, indicating compelling semipermanent superior appreciation potential. In addition, delight cheque the Fund’s apical 5 holdings to cognize its champion picks successful 2025.

In its fourth-quarter 2025 capitalist letter, Invesco Small Cap Value Fund highlighted stocks similar Globus Medical, Inc. (NYSE:GMED). Globus Medical, Inc. (NYSE:GMED) is simply a aesculapian instrumentality institution that develops musculoskeletal solutions, including spinal implants and surgical technologies. The one-month instrumentality of Globus Medical, Inc. (NYSE:GMED) was 2.83% portion its shares traded betwixt $51.79 and $101.40 implicit the past 52 weeks. On March 04, 2026, Globus Medical, Inc. (NYSE:GMED) banal closed astatine astir $90.46 per share, with a marketplace capitalization of astir $12.17 billion.

Invesco Small Cap Value Fund stated the pursuing regarding Globus Medical, Inc. (NYSE:GMED) in its Q4 2025 capitalist letter:

"Globus Medical, Inc. (NYSE:GMED): This aesculapian exertion institution specializes successful musculoskeletal solutions for spine, orthopedic trauma and associated reconstruction. The institution has faced issues with caller acquisitions, proviso concatenation issues and weakness successful its robotics segment, which unneurotic provided an accidental to acquisition the banal astatine what we saw arsenic an charismatic discount to our estimation of intrinsic value."

Globus Medical, Inc. (GMED) Slips connected Acquisition and Robotics Segment Challenges

Globus Medical, Inc. (NYSE:GMED) is not connected our database of 40 Most Popular Stocks Among Hedge Funds Heading Into 2026. As per our database, 42 hedge money portfolios held Globus Medical, Inc. (NYSE:GMED) at the extremity of the 4th quarter, which was 46 successful the erstwhile quarter. While we admit the hazard and imaginable of Globus Medical, Inc. (NYSE:GMED) as an investment, our condemnation lies successful the content that immoderate AI stocks clasp greater committedness for delivering higher returns and doing truthful wrong a shorter clip frame. If you're looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.

Read Entire Article